Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON25164Phase 3Not yet recruiting
Phase 3, randomised, open-label trial of ferrous fumarate and folic acid in postpartum anemia (3 arms), sponsored by TweeSteden Ziekenhuis. Primary endpoint: Increase in hemoglobin. Planned start Mar 2008; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON25164.